The Carlyle Group Receives Approval to Buy Destimoney’s Indian Arm (Asia)

The Competition Commission of India has approved Mauritius-based financial services company Destimoney Enterprises’ proposed sale of its Indian arm to Quality Investment Holdings, an entity controlled by alternative asset manager The Carlyle Group, for a reported US$200 million. Carlyle will acquire a 100 percent stake in Destimoney Enterprises’ Indian arm. Read More

InvAscent’s India Life Sciences Fund II Invests Across Two Medical Device Companies (Asia)

India-focused private equity firm InvAscent has invested INR920 million (approximately US$15 million) across two India-based medical device companies: Comprehensive Prosthetics and Orthotics (CPO), a manufacturer of artificial limbs, and Relisys, a manufacturer of medical devices that treat life-threatening diseases. The transactions were structured through India Life Sciences Fund II. InvAscent… Read More

Legal & Regulatory Bulletin – Issue No. 13, Winter 2015

Thank you for sharing your thoughts and comments on issues of concern to you and opportunities identified in the EMPEA Legal & Regulatory Bulletin. Your thought leadership and participation through the Bulletin and EMPEA’s other delivery channels inform EMPEA’s engagement with government policymakers and regulators. To deepen that engagement, in… Read More

AIF Capital Exits Famy Care Through a Strategic Sale to Mylan (Asia)

Global pharmaceutical company Mylan has signed a definitive agreement to acquire certain female health care businesses from India-based oral contraceptive pill manufacturer Famy Care for US$750 million, plus additional contingent payments of up to US$50 million, facilitating an exit for Asia-focused private equity firm AIF Capital. AIF Capital originally invested… Read More

Private Equity Through Debt: Opportunities for Private Equity in India

Introduction1 There appears to be a recent trend in Indian PE circles with increasing number of PE players raising (or planning to raise) offshore funds which are able to invest in rupee denominated non-convertible debt in India (“NCDs”) along with equity. What is this reason for this? With Indian equity markets looking up, is this… Read More

Navis Capital Partners Raises US$1.5 Billion for Its Seventh Fund (Asia)

Southeast Asia-focused private equity firm Navis Capital Partners has closed its seventh private equity vehicle with US$1.5 billion in capital commitments. The fund, which had originally targeted US$1.25 billion, reached a US$860 million first close in December 2013. The final close included the addition of a shariah-compliant parallel vehicle. The… Read More

Clearwater Partially Exits Oricon Enterprises (Asia)

Clearwater Capital, an investment firm focused on credit and special situations in Asia, has partially exited India-based Oricon Enterprises by selling 850,000 shares on 14 January and 4.5 million shares on 29 January through open market transactions on the Bombay Stock Exchange. Clearwater returned INR40.4 million (approximately US$650,000) and INR223… Read More



(default archive template)